Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies

Taylor and Francis Group, Expert Opinion on Biological Therapy, 9(18), p. 937-945, 2018

Journal article published in 2018 by Vincenzo di Noia, Ettore D’Argento

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by